Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 560 · FY2024 2,200 — 3-yr total 2,760
Georgian distribution arm of Berlin-Chemie/Menarini, the Italian-German pharmaceutical group, marketing its prescription medicines locally.
Subsidiary of Shezghuduli Pasukhismgeblobis Sazogadoeba Berlin Hemi 72445 Distribushens (100.0%)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 12,286 | 19,530 | 17,568 | 15,487 | 15,330 | 27,074 | 15,487 | +3.9% | |
| 1,483 | 1,568 | 1,170 | 800 | 489 | 309 | 303 | -23.3% | |
| TOTAL ASSETS | 13,769 | 21,098 | 18,738 | 16,287 | 15,819 | 27,383 | 15,790 | +2.3% |
| 14,086 | 20,605 | 11,840 | 7,436 | 6,377 | 17,001 | 5,774 | -13.8% | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| TOTAL LIABILITIES | 14,086 | 20,605 | 11,840 | 7,436 | 6,377 | 17,001 | 5,774 | -13.8% |
| 317 | 493 | 6,898 | 8,851 | 9,442 | 10,382 | 10,016 | nmf | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 2,127 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 87 | 1,818 | 686 | 169 | 2,068 | 2,313 | 1,049 | +51.4% |
| Net Debt | 2,040 | 1,818 | 686 | 169 | 2,068 | 2,313 | 1,049 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.